eli lilly news - Search News

Eli Lilly, Novo Nordisk

MarketWatch on MSN · 2h

Eli Lilly & Co. stock underperforms Monday when compared to competitors

Supported by world-class markets data from Dow Jones and FactSet, and partnering with Automated Insights, MarketWatch Automation brings you the latest, most pertinent content at record speed and with unparalleled accuracy. Back To Top

Insider Monkey on MSN · 2d

Is Eli Lilly and Company (LLY) an Unstoppable Dividend Stocks to Buy?

We recently compiled a list of the 10 Unstoppable Dividend Stocks to Buy. In this article, we will have a look at where Eli Lilly and Company (NYSE:LLY) ranks among other unstoppable dividend stocks to buy.

Reuters on MSN · 3d

Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production

Eli Lilly is investing $1.8 billion across two manufacturing sites in Ireland to boost production of its hugely popular obesity drug and a newly approved treatment for Alzheimer's, the drugmaker said on Thursday.

Eli Lilly, Ebglyss

YAHOO!Finance · 5h

Eli Lilly Scores FDA Approval For Eczema Treatment Ebglyss

Ebglyss (lebrikizumab-lbkz), a targeted IL-13 inhibitor, for adults and children 12 years of age and older who weigh at least 88 pounds (40 kg) with moderate-to-severe atopic dermatitis (eczema) that is not well controlled despite treatment with topical prescription therapies.

BioWorld · 10m

Lilly’s Ebglyss enters US atopic dermatitis market with FDA nod

Eli Lilly and Co.’s Ebglyss (lebrikizumab) becomes the latest U.S. entrant in the increasingly competitive atopic dermatitis space, following FDA approval of the IL-13-targeting antibody, which will now go up against other biologics such as established blockbuster Dupixent (dupilumab,

Reuters on MSN · 8h

US FDA approves Eli Lilly's drug for eczema

Eli Lilly said on Friday the U.S. Food and Drug Administration approved its eczema drug for use in adults and children above 12 years old. The drug, which is an injectable medicine and branded Ebglyss,

New eczema drug from Eli Lilly receives FDA approval for children and adults

On Friday, the U.S. Food and Drug Administration approved Eli Lilly's eczema drug for use in adults and children 12 and ...

1don MSN

World’s Biggest Hedge Fund Sells Apple, Eli Lilly Stock, and Buys Microsoft, Moderna

Bridgewater Associates slashed a stake in Apple, halved its Lilly investment, doubled down on Microsoft, and bought Moderna ...

6d

Eli Lilly’s new CFO is a 23-year company veteran—showing how pharma firms rely on a ‘deep bench of qualified talent’

Good morning. Eli Lilly and Company has promoted longtime executive Lucas Montarce to the role of CFO. The move is similar to ...

5d

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound)

Forget Mounjaro: 1 Reason Investors Should Love Eli Lilly Stock Even More (Hint: I'm Not Talking About Zepbound) ...

15h

Barclays Reaffirms Their Buy Rating on Eli Lilly & Co (LLY)

In a report released today, Carter Gould from Barclays maintained a Buy rating on Eli Lilly & Co (LLY – Research Report), with a ...

3don MSN

Eli Lilly wins buy as Citi resumes coverage on obesity prospects

After a period of rating suspensions, Citi resumed its coverage on Eli Lilly (NYSE:LLY) with a buy recommendation and a ...

3d

6 Incredible Reasons to Invest in Eli Lilly

Sold under the brand names Mounjaro and Zepbound, tirzepatide has been an incredible growth driver for Eli Lilly. In 2022 -- ...

FierceBiotech3d

Eli Lilly sells Life Sciences Studio lab to Arctoris, moving automation platform from San Diego to Oxford

Four years after launching a remote-controlled robotic laboratory in San Diego, Eli Lilly is shipping the operation overseas.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results